ABEMACARE: Abemaciclib in combination with endocrine therapy as first line therapy in metastatic breast cancer patients with symptomatic visceral metastases or high tumor burden - Kotzur, Franziska; Bidner, Helen; Bronger, Holger; Egert, Silvia; Fasching, Peter; Fischer, Dorothea; Kehl, Victoria; Luck, Hans-Joachim; Muller, Lothar; Reuning, Ute; Rief, Lukas; Rosch, Romina; et al. (CANCER RESEARCH, 2021)
CRIS-Team WoS Importer:2021-03-26